U.S. Food and Drug Administration

Featured

Lung Illnesses Associated with Use of Vaping Products

Information for the Public, FDA Actions, and Recommendations

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

composite image showing concept of FDA research and technology

FDA’s Technology Modernization Action Plan

The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Closeup shot of a nurse holding a patient's hand in comfort in a hospital

Combating the Opioid Crisis

FDA takes actions to combat prescription opioid abuse.

Nov 15

Statement from Sarah Yim, M.D., acting director of the Office of Therapeutic Biologics and Biosimilars in the FDA’s Center for Drug Evaluation and Research, on FDA’s continued progress facilitating competition in the biologic marketplace with approval of 25th biosimilar product

Nov 15

FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease

More Press Announcements

Newsroom Meetings Testimony Speeches

Nov 19

Precision Dose Inc. Issues Voluntary Nationwide Recall of Ranitidine Oral Solution, USP 150 mg/10 mL Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity.

Drugs

Nov 15

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Ranitidine Hydrochloride 150mg and 300mg Capsules (Manufactured by Novitium Pharma LLC) Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)

Drugs

Nov 15

Select Varieties of Breakstone’s Cottage Cheese are Voluntarily Being Recalled Due to Potential Presence of Foreign Material

Food & Beverages

Cybersecurity conceptual graphic featuring white dots of various sizes in three dimensional space connected by white lines against a dark blue background, reminiscent of a constellation diagram, with an image of a padlock in the center of the graphic.

Patient Engagement, Awareness and Medical Device Cybersecurity

To help better communicate medical device cybersecurity risks to patients, the FDA goes straight to the source.

FDA Principal Deputy Commissioner Dr. Amy Abernethy reflects on the importance of incorporating patient perspectives into decisions about new and developing therapies.

Patient Perspective Is Vital to FDA's Work

FDA considers patients the real experts when it comes to their health conditions, as illustrated in the recent rare disease disorder summit.

collage of three separate images including a smiling young cancer patient with a scarf around her head, a tired or concerned nurse leaning against a wall pressing her fingers to her forehead, and a closeup of a syringe drawing clear liquid from a vial

To Help Reduce Drug Shortages, We Need Manufacturers to Sell Quality

Drug manufacturers with very high reliability usually have a mature quality management system — purchasers should have the ability to readily identify them.

Nov 20